This research demonstrates an improved editing efficiency for C-to-A, G-to-A, and T-to-A conversions in human cells, indicating a significant advancement in base editing technology.
Abstract Base editing technology enables single-nucleotide conversions without donor templates or DNA double-strand breaks (DSBs), yet current base editors lack the capacity to efficiently address C-to-A, G-to-A, or T-to-A conversion. Here we report the development of B-to-A base editors (BABEs, B=C/G/T) through co-expressing certain glycosylase-based base editors together with the engineered translesion synthesis (TLS) polymerase polη Q38S variant, achieving about an average of 5-fold increase in B-to-A editing purity and efficiency. The C-to-A base editor (CABE), G-to-A base editor (GABE), and T-to-A base editor (TABE) achieved C-to-A purity up to 69.0%, G-to-A purity up to 57.1% and T-to-A purity up to 91.6%, respectively, in human cells without compromising the editing efficiency. In addition, we enhanced the editing efficiency of gGBE through rational design and further developed more efficient G-to-A base editor (GABEv2), which displayed a 2.1-fold improvement in G-to-A editing purity and efficiency compared to gGBE in mouse embryo. Our study expands current base editor toolbox by providing B-to-A base editors, broadening the applications of base editors in fundamental research and clinical therapeutics.
No takes yet. Share an insight, caveat, or question.
Liang et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: